FBRX
Forte Biosciences Inc.
$12.64
-$0.30(-2.32%)
42
Overall
60
Value
40
Tech
28
Quality
Market Cap
$167.35M
Volume
30.15K
52W Range
$4.12 - $28.68
Target Price
$63.33
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $36.0K | -- | -- | -- | -- | -- | ||
| Total Revenue | $36.0K | -- | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $36.0K | -- | -- | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $4.1M | $46.3M | $21.5M | $13.9M | $32.5M | $36.6M | ||
| Research & Development | $2.7M | $42.1M | $13.9M | $5.6M | $21.9M | $20.7M | ||
| Research Expense | $2.7M | $42.1M | $13.9M | $5.6M | $21.9M | $20.7M | ||
| Selling, General & Administrative | $1.4M | $4.2M | $7.6M | $8.3M | $10.6M | $15.4M | ||
| General & Administrative Expenses | $1.4M | $4.2M | $7.6M | $8.3M | $10.6M | $15.4M | ||
| Salaries & Wages | -- | -- | -- | -- | $3.3M | $3.1M | ||
| Depreciation & Amortization | $-843.0K | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-843.0K | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $-61.5M | $52.0K | $100.0K | $19.0K | $-94.0K | $-160.0K | ||
| OPERATING INCOME | ||||||||
| Operating income | $-4.1M | $-46.3M | $-21.5M | $-13.9M | $-32.5M | $-36.6M | ||
| EBITDA | $-4.1M | $-14.2M | $-21.4M | $-13.9M | $-32.6M | $-36.8M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $3.8M | -- | -- | $-162.0K | $-1.1M | $-1.3M | ||
| Intinc | $1.6M | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-2.3M | -- | -- | $-162.0K | $1.1M | $1.3M | ||
| Gain on Sale of Securities | $33.0K | -- | -- | -- | $4.0K | $7.0K | ||
| Other Income/Expense | $5.0K | $205.0K | $222.0K | $-145.0K | $114.0K | $190.0K | ||
| Other Special Charges | $-5.0K | $-205.0K | $-222.0K | $-145.0K | $-114.0K | $-190.0K | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | $-200.0K | -- | -- | -- | -- | -- | ||
| Special Income Charges | $200.0K | -- | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | $61.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-4.1M | $-14.2M | $-21.5M | $-13.9M | $-32.6M | $-36.8M | ||
| Pre-Tax Income | $-4.1M | $-46.5M | $-21.7M | $-13.9M | $-31.5M | $-35.0M | ||
| INCOME TAX | ||||||||
| Tax Provision | $1.0K | $-3.2M | $-67.0K | $-79.0K | -- | $-2.0K | ||
| NET INCOME | ||||||||
| Net Income | $-4.1M | $-46.5M | $-21.7M | $-13.9M | $-31.5M | $-35.5M | ||
| Net Income (Continuing Operations) | $-4.1M | $-46.5M | $-21.7M | $-13.9M | $-31.5M | $-35.5M | ||
| Net Income (Discontinued Operations) | $-4.1M | $-46.5M | $-21.7M | $-13.9M | $-31.5M | $-35.5M | ||
| Net Income (Common Stockholders) | $-4.1M | $-46.5M | $-21.7M | $-13.9M | $-31.5M | $-35.5M | ||
| Normalized Income | $-3.2M | $-49.8M | $-21.7M | -- | -- | $-35.0M | ||
| TOTALS | ||||||||
| Total Expenses | $4.1M | $46.3M | $21.5M | $13.9M | $32.5M | $36.6M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $945.2K | $294.4K | $558.7K | $695.3K | $1.3M | $2.9M | ||
| Average Shares Outstanding (Diluted) | $945.2K | $294.4K | $558.7K | $695.3K | $1.3M | $2.9M | ||
| Shares Outstanding | $956.0K | $540.4K | $590.5K | $840.3K | $1.5M | $6.6M | ||
| Basic EPS | $-67.25 | $-158 | $-38.75 | $-20 | $-25 | $-12.17 | ||
| Basic EPS (Continuing Operations) | $-67.25 | $-158 | $-38.75 | $-20 | $-25 | $-12.17 | ||
| Diluted EPS | $-67.25 | $-158 | $-38.75 | $-20 | $-25 | $-12.17 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-20 | $-25 | $-12.17 | ||
| OTHER METRICS | ||||||||
| Gain On Sale Of P P E | $-1.2M | -- | -- | -- | -- | -- | ||
| Other Gand A | $1.4M | $4.2M | $7.6M | $8.3M | $10.6M | $15.4M | ||
| Realized Capital Gain | $1.4M | -- | -- | -- | -- | -- | ||
| Restruct | $-200.0K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FBRX | $12.64 | -2.3% | 30.15K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |